IP Group PLC Further re Scrip Dividend (4936Z)
15 September 2022 - 1:33AM
UK Regulatory
TIDMIPO
RNS Number : 4936Z
IP Group PLC
14 September 2022
FOR RELEASE ON 14 September 2022
IP Group plc - Further re Scrip Dividend
IP Group plc (LSE: IPO) ("IP Group" or "the Group" or "the
Company"), which develops world-changing science and technology
businesses across life sciences, technology and cleantech,
announces that, further to the announcements dated 03 August 2022,
18 August 2022 and 13 September 2022 in connection with the Interim
Scrip Dividend, the Group has received valid elections from
shareholders resulting in a requirement to issue 154,718 new
ordinary shares of 2p each ("New Shares").
An application has been made for the New Shares to be issued in
connection with the Scrip Dividend to be admitted to the premium
segment of the Official List of the Financial Conduct Authority and
to trading on the main market for listed securities of the London
Stock Exchange respectively.
Admission of the New Shares is expected to be effective on 20
September 2022. Following admission and in accordance with the
Disclosure Guidance and Transparency Rules of the Financial Conduct
Authority, the Group will have 1,063,188,005 Ordinary Shares in
issue and 28,607,622 Ordinary Shares in Treasury.
The total number of Ordinary Shares with voting rights following
the issue of the New Shares will be 1,034,580,383 Ordinary Shares.
This figure may be used by shareholders in the Group as the
denominator for the calculation by which they will determine if
they are required to notify their interest in, or a change to their
interest in, the share capital of the Group under the Disclosure
Guidance and Transparency Rules of the Financial Conduct
Authority.
For more information, please contact:
IP Group plc www.ipgroupplc.com
David Baynes, Chief Financial and +44 (0) 20 7444 0050
Operating Officer +44 (0) 20 7444 0062/+44 (0)
Liz Vaughan-Adams, Communications 7967 312125
Notes for editors
About IP Group
IP Group develops world-changing science and technology
businesses across life sciences, technology and cleantech (through
Kiko Ventures). The Group has a strong track record of success,
having been the founder investor in a number of high-profile
companies including Oxford Nanopore Technologies plc, and has one
of the most exciting portfolios of high-growth businesses in
Europe. The Group also owns Parkwalk, the UK's largest growth EIS
fund manager which backs world-changing technologies emerging from
the UK's leading universities and research institutions. IP Group
is listed on the Main Market of the London Stock Exchange under the
code IPO.
For more information, please visit our website at
www.ipgroupplc.com .
ENDS
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
RNS may use your IP address to confirm compliance with the terms
and conditions, to analyse how you engage with the information
contained in this communication, and to share such analysis on an
anonymised basis with others as part of our commercial services.
For further information about how RNS and the London Stock Exchange
use the personal data you provide us, please see our Privacy
Policy.
END
FURGPUGWBUPPGAC
(END) Dow Jones Newswires
September 14, 2022 11:33 ET (15:33 GMT)
Ip (LSE:IPO)
Historical Stock Chart
From Apr 2024 to May 2024
Ip (LSE:IPO)
Historical Stock Chart
From May 2023 to May 2024